Review
Published on 15 Jun 2023
Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170436
- 4,545 views
- 6 citations
Type at least 3 characters
1,477 articles
Editorial
Published on 14 Jun 2023
Editorial: Eicosanoids in cancer, Volume II
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1224623
- 1,680 views
- 2 citations
Editorial
Published on 13 Jun 2023
Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228406
- 2,214 views
Original Research
Published on 08 Jun 2023
Administration of protopine prevents mitophagy and acute lung injury in sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1104185
- 4,763 views
- 14 citations
Review
Published on 08 Jun 2023
Role of heparanase in ARDS through autophagy and exosome pathway (review)
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200782
- 3,995 views
- 5 citations
Original Research
Published on 08 Jun 2023
Metformin alleviates lung-endothelial hyperpermeability by regulating cofilin-1/PP2AC pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1211460
- 3,149 views
- 5 citations
Systematic Review
Published on 07 Jun 2023
Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189389
- 9,762 views
- 25 citations
Editorial
Published on 05 Jun 2023
Editorial: Insights in inflammation pharmacology: 2022
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1223761
- 1,651 views
Review
Published on 02 Jun 2023
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1196413
- 20,952 views
- 43 citations
Original Research
Published on 01 Jun 2023
The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1195567
- 6,457 views
- 7 citations
Review
Published on 01 Jun 2023
Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1168990
- 5,291 views
- 21 citations
Review
Published on 01 Jun 2023
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178596
- 10,120 views
- 29 citations
Correction
Published on 30 May 2023
Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219760
- 3,793 views
- 6 citations
Review
Published on 30 May 2023
Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186016
- 6,271 views
- 13 citations
Correction
Published on 25 May 2023
Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1220144
- 1,445 views
Editorial
Published on 19 May 2023
Editorial: Pathogenesis of diabetic foot ulcers
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218201
- 4,709 views
- 6 citations